Ilian Iliev Ph.D Overview
- Firm
- EMV Capital
- Primary Position
-
Chief Executive...
- Primary Industry
-
Information Technology
- Active Board Seats
-
8
- Med. Deal Size
-
- Med. Valuation
-
Ilian Iliev Ph.D General Information
Biography
Dr. Ilian Iliev serves as a Board Member at PDS Biotechnology. He served as Managing Director at EMV Capital. He also serves as Executive Director at Martlet Capital. He serves as a Board Member at Proaxsis. He serves as a Board Member at Wanda. He serves as Chairman at Wanda Health. He serves as Chief Executive Officer at NetScientific. He serves as a Board Member at Glycotest, Sofant Technologies, and Q-Bot. EMV Capital (EMVC), a corporate finance and VC investment firm acquired by NetScientific in August 2020. He co-owned Boliven. EMVC is a London-based investor in the industrial sustainability, industrials, and healthcare sectors. EMVC's investments in Europe, Israel, and the US cover a range of technologies including robotics and AI, machine learning, materials science, IoT, advanced engineering, power electronics, and medical devices. He spun out EMV Capital out of EcoMachines Ventures, which he co-founded in 2013. Prior to that, he co-founded and was CEO of Cambridge Ltd (2006-2012), which he built into a leading market and technology business intelligence provider in the UK. He is a board member at a number of Net Scientific and EMVC portfolio companies, including PDS Biotechnology Inc., Pointgrab, and Q-Bot, and he also serves as chairman at Vortex Biosciences. He holds a Ph.D. from Cambridge University's Judge Business School, focused on Venture Capital business models in emerging economies, a Mcom in Economics, and a BA in Politics, Economics, and International Relations from the University of Witwatersrand, South Africa. He has published widely on entrepreneurship, venture capital, and market trends in energy and healthcare, and has won awards for academic excellence.
Contact Information
Address
- 20 Saint Andrew Street
- London EC4A 3AG
- England, United Kingdom
Ilian Iliev Ph.D Positions (2)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
EMV Capital | Investor | Chief Executive Officer | London, United Kingdom | Venture Capital | |
Martlet Capital | Investor | Executive Director | Cambridge, United Kingdom | Venture Capital |
Ilian Iliev Ph.D Board Seats (8)
Company | Industry | Ownership Status | Financing Status | Location | Since |
---|---|---|---|---|---|
Glycotest | Biotechnology | Privately Held (backing) | Venture Capital-Backed | Merion, PA | |
PDS Biotechnology | Biotechnology | Publicly Held | Formerly VC-backed | Princeton, NJ | |
PointGrab | Business/Productivity Software | Privately Held (backing) | Venture Capital-Backed | Kfar Saba, Israel | |
ProAxsis | Diagnostic Equipment | Privately Held (backing) | Venture Capital-Backed | Belfast, United Kingdom | |
Q-Bot | Other Hardware | Privately Held (backing) | Venture Capital-Backed | London, United Kingdom |
Ilian Iliev Ph.D Lead Partner on Deals (27)
Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
---|---|---|---|---|---|---|
Sofant | 05-Jun-2024 | Later Stage VC | Completed | Wireless Communications Equipment | Edinburgh, United Kingdom | |
DeepTech Recycling | 31-May-2024 | Completed | Environmental Services (B2B) | London, United Kingdom | ||
Martlet Capital | 13-May-2024 | Completed | Other Financial Services | Cambridge, United Kingdom | ||
Glycotest | 23-Jan-2024 | Completed | Biotechnology | Merion, PA | ||
ProAxsis | 01-Jan-2024 | Completed | Diagnostic Equipment | Belfast, United Kingdom | ||
Q-Bot | 13-Sep-2023 | Completed | Other Hardware | London, United Kingdom | ||
DName-iT | 30-Jun-2023 | Completed | Laboratory Services (Healthcare) | Belfast, United Kingdom | ||
Vortex Biotech | 22-Jun-2023 | Completed | Environmental Services (B2B) | Dubai, United Arab Emirates | ||
Sofant | 29-Nov-2022 | Later Stage VC (Series A) | Completed | Wireless Communications Equipment | Edinburgh, United Kingdom | |
Sofant | 29-Nov-2022 | Later Stage VC (Series A) | Completed | Wireless Communications Equipment | Edinburgh, United Kingdom |
Ilian Iliev Ph.D Network (163)
Board Members (66)
Name | Company | Representing | Location | From |
---|---|---|---|---|
Tomasz Lipinski | Q-Bot | Q-Bot | London, United Kingdom | |
Yuejian Zhang | Glycotest | Fosun Pharma | Merion, PA | |
Vortex Biosciences | Vortex Biosciences | Pleasanton, CA | ||
Glycotest | Self | Merion, PA | ||
PDS Biotechnology | Edge Therapeutics | Princeton, NJ |
Portfolio Executives (97)
Name | Company | Role | Deal date | Location |
---|---|---|---|---|
Tughrul Arslan Ph.D | Sofant | Co-Founder, Board Member & Chief Scientist | 05-Jun-2024 | Edinburgh, United Kingdom |
Victor Steel | Sofant | Chief Technology Officer, Technology Lead & Chief Marketing Officer | 05-Jun-2024 | Edinburgh, United Kingdom |
Sofant | Co-Founder, Board Member, Chief Scientific Officer & Vice President, Engineering | 05-Jun-2024 | Edinburgh, United Kingdom | |
Sofant | Co-Founder, Board Member & Chief Operating Officer | 05-Jun-2024 | Edinburgh, United Kingdom | |
Sofant | Chief Executive Officer & Board Member | 05-Jun-2024 | Edinburgh, United Kingdom |
Ilian Iliev Ph.D Affiliated Funds (2)
Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
---|---|---|---|---|---|---|---|---|
EMVC Evergreen EIS Fund | EMV Capital (Acquired) | Venture Capital - Early Stage | Evergreen | |||||
EMV Capital Thematic Fund | EMV Capital (Acquired) | Venture Capital - Early Stage | Upcoming |
Ilian Iliev Ph.D FAQs
-
Who is Ilian Iliev Ph.D?
Dr. Ilian Iliev serves as a Board Member at PDS Biotechnology.
-
How much does Ilian Iliev Ph.D typically invest?
Ilian Iliev Ph.D's median deal size is
. -
What is Ilian Iliev Ph.D’s main position?
Ilian Iliev Ph.D’s primary position is Chief Executive Officer.
-
What are the contact details for Ilian Iliev Ph.D?
Ilian Iliev Ph.D’s email address is ii
and his phone number is +44 07786 . -
How many active board seats does Ilian Iliev Ph.D hold?
Ilian Iliev Ph.D holds 8 board seats including Glycotest, PDS Biotechnology, PointGrab, ProAxsis, and Q-Bot.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »